Bringing a new cancer drug to market
Two decades ago, Poul Sorensen made a discovery that would lead to the development of a cancer drug that shrinks many different kinds of tumours.
UBC researchers find gene signature that predicts outcome after spinal cord injury
The authors, including MD/PhD students, integrated data from decades of small-scale studies using a systems biology approach.
Lowering levels of Huntington disease-causing protein restores cognitive function in mice
After receiving pieces of DNA called antisense oligonucleotides, the mice also became less anxious and depressed.
Midwifery linked to lower odds of birth complications for low-income women
The researchers looked at records for 58,000 British Columbia women, looking for incidence of small-for-gestational age birth, pre-term birth and low birth weight for low-income women.
Child abuse could leave “molecular scars” on its victims
The researchers found a distinctive and significant difference in chemical tags on 12 regions of the genome.
Cannabis use could help people stay on treatment for opioid addiction
Daily use of cannabis was associated with a 21 per cent higher chance of remaining in opioid agonist treatment programs.
Hardwired for laziness? Tests show the human brain must work hard to avoid sloth
Moving avatars toward pictures of physical activity required volunteers’ brains to work harder.
More specialized harm reduction services needed for women who use drugs
Some overdose prevention sites are perceived as “masculine” spaces.
HPV vaccine shows higher failure rate in girls or women living with HIV
Researchers compared health outcomes of a group of vaccinated Canadian women and girls with HIV with a previously-studied cohort of vaccinated women and girls without HIV.
Rare but recurring mutations discovered in ER-positive breast cancer
The uncommon mutations were associated with early relapse and death, and thus stand out as therapeutic targets.